BioSpace News Archive

Selvita (WSE: SLV) today announced that following the Shareholder Meeting of the Company which took place today, shareholders have adopted a resolution to approve the plan to separate the Selvita oncology therapeutics and contract research business units into two independent companies.

INTELLiSTEM Technologies, an international company revolutionizing stem cell medicine, today announced that they have created genetically engineered Super Sentinel Cells™ (SSC’s) to effectively target cancer cells.

UnitedHealthcare will offer a new Medicare Advantage plan in the Bay Area featuring Canopy Health care providers.

River Ridge Dermatology welcomed two new resident physicians, Karla Guerra, D.O. and Abby Russell, D.O., and bid farewell to Dr. Nathan Miller, who completed his residency.

The U.S. Food and Drug Administration today announced that, as a first step toward implementation of the recently established Safety and Performance Based Pathway for medical devices, the agency is issuing draft guidances outlining the recommended premarket performance criteria and testing methodologies for four specific types of devices

SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively

Equality Health®, the Phoenix-based technology-enabled whole-health delivery system, and Signify Health, a health services company that integrates technology and data with clinical and social care, intend to dramatically improve health outcomes and experience for Arizona’s Medicaid population with the launch of state-of-the-art technology

The smallpox treatment market report has been added to Technavio’s catalog.

Company Enters into Cooperation Agreement with Newtyn Management and Western Standard

PROMISE II is a multi-center, prospective, single-arm study to be conducted in the U.S. and Japan.